List of Excipients in API etrasimod
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing etrasimod
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | VELSIPITY | etrasimod | 0069-0274 | CELLULOSE, MICROCRYSTALLINE | 2028-10-12 |
| Pfizer Laboratories Div Pfizer Inc | VELSIPITY | etrasimod | 0069-0274 | FD&C BLUE NO. 1 ALUMINUM LAKE | 2028-10-12 |
| Pfizer Laboratories Div Pfizer Inc | VELSIPITY | etrasimod | 0069-0274 | FD&C BLUE NO. 2 ALUMINUM LAKE | 2028-10-12 |
| Pfizer Laboratories Div Pfizer Inc | VELSIPITY | etrasimod | 0069-0274 | FD&C YELLOW NO. 5 ALUMINUM LAKE | 2028-10-12 |
| Pfizer Laboratories Div Pfizer Inc | VELSIPITY | etrasimod | 0069-0274 | MAGNESIUM STEARATE | 2028-10-12 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for etrasimod
Excipient focus: CELLULOSE, MICROCRYSTALLINE
etrasimod drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
etrasimod drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
etrasimod drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE
etrasimod drug variants containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
etrasimod drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
etrasimod drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
etrasimod drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
etrasimod drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
etrasimod drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
etrasimod drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
etrasimod drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | etrasimod | 0069-0274 |
| US Pharmaceuticals | etrasimod | 63539-274 |
| >Company | >Ingredient | >NDC |
etrasimod drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
